Navigation Links
Patient Safety in Challenging Economic Times is Focus of NPSF Annual Congress on May 20-22
Date:1/13/2009

BOSTON, Jan. 13 /PRNewswire/ -- Responding to the increased risk to patient safety in an economic downturn, the National Patient Safety Foundation has announced that the 2009 NPSF Patient Safety Congress will directly address this issue through an extensive program of educational sessions designed to provide attendees with the new thinking and tools critical to keeping patients safe.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080307/AQF053LOGO)

This highly acclaimed annual event, to be held May 20-22 at the Gaylord National outside Washington, DC, boasts over 35 individual sessions targeting seven core areas essential to patient safety. In addition, insightful and inspiring plenaries are planned, including a town hall meeting with authors of the pivotal Institute of Medicine report "To Err Is Human" and distinguished members of the Lucian Leape Institute. Intensive full-day pre-Congress programs will also be offered, highlighted by a unique executive-level event providing case studies and discussion focused on successfully building a safety framework, setting safety and quality priorities, and ensuring critical physician engagement. Plus, the NPSF Congress provides direct access to a wide array of innovative solutions providers.

"These times demand increased vigilance from us all," explained Diane Pinakiewicz, President of the National Patient Safety Foundation, "and, as adversity threatens, it also sparks creativity and unique problem-solving, a mindset that is at the very heart of this year's Congress."

Widely recognized as the definitive patient safety event each year, the 2009 NPSF Congress will provide the new learnings, practical tools, and innovative solutions essential to keeping patients safe during these challenging times, and will offer unparalleled opportunities for attendees to collaborate with safety experts and influential healthcare leaders.

"Now more than ever, an unwavering focus on patient safety is critical," noted Ms. Pinakiewicz. "The risks are too great to respond otherwise."

Visit http://www.npsf.org for complete program details and registration information. Attendees may also register by calling 401.766.4904.

About the National Patient Safety Foundation

The National Patient Safety Foundation is an independent not-for-profit 501(c)(3) organization that has been diligently pursuing one mission since its founding in 1997 -- to improve the safety of patients. NPSF also occupies a unique position by virtue of its inclusive, multi-stakeholder approach, which fosters collaboration on the issue of patient safety.


'/>"/>
SOURCE National Patient Safety Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
7. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
8. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
9. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
10. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
11. Ortho Biotech Supports FDA Advisory Committees Recommendations on Use of ESAs in Chronic Renal Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2017)... ARLINGTON, Va. , Jan. 13, 2017  The ... following statement in response to FDA final guidance ... FDA for its continued leadership in emphasizing the importance ... members are keenly aware of the benefits biosimilars will ... costs.   Yet the portion of the ...
(Date:1/13/2017)... ... 13, 2017 , ... FireflySci, in response to several customers’ ... solutions for measurements where traditional cuvette applications are not convenient. For instance, a ... sample that would not fit into a typical cuvette inside a spectrophotometer. In ...
(Date:1/12/2017)... ... January 12, 2017 , ... After her brain ... doctors gave her only a few months to live. Now a paper publishing ... stabilized Rosendahl’s disease and increased both the quantity and quality of her life: ...
(Date:1/12/2017)... (PRWEB) , ... January 12, ... ... market’s rapid adoption of Limfinity® Cloud, RURO has enhanced the platform to ... user groups, federated login, rapid data searching, and more. In addition to ...
Breaking Biology Technology:
(Date:12/15/2016)... Germany , December 15, 2016 ... today announced an agreement with NuData Security, an award-winning ... The partnership will enable clients to focus on good customer ... data protection regulation. ... In order to provide a one-stop fraud prevention ...
(Date:12/15/2016)... Advancements in biometrics will radically ... wellbeing (HWW), and security of vehicles by ... vehicles begin to feature fingerprint recognition, iris ... monitoring, brain wave monitoring, stress detection, fatigue ... detection. These will be driven by built-in, ...
(Date:12/12/2016)... CLEVELAND , Dec. 12, 2016  Researchers ... commercial possibilities for graphene by combining the material ... a highly sensitive pressure detector able to sense ... of a small spider.  The ... and can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):